School of Medicine
Showing 1-50 of 63 Results
Professor of Medicine (Primary Care and Population Health)
Bio Dr. Deborah Kado joined the faculty at Stanford and the Veteran's Association Medical Center, Palo Alto in April 2021 as Chief of Geriatric Research in the Geriatrics Section/Population Health and Primary Care. She completed her undergraduate education at Bryn Mawr College followed by medical school at Cornell University Medical College. Originally from Northern California, she returned back west to complete her medical residency in internal medicine and chief residency at Harbor-UCLA Medical Center. From there, she headed to UCSF for her post-doctoral research training in clinical research, followed by a Master’s Degree of Science in Epidemiology at the UCLA School of Public Health sponsored by the John Hartford Foundation, and a clinical fellowship in geriatrics at UCLA. Her primary research focus has been on osteoporosis and the related disorder hyperkyphosis. She has enjoyed continuous funding from the NIH since she started on the UCLA faculty in 2000 and in 2007 defined hyperkyphosis as a new geriatric syndrome, first featured in the Annals of Internal Medicine and later as its own chapter in UpToDate. Prior to coming to Stanford, she was at UC San Diego where she started a dedicated osteoporosis clinic in 2013, and in about 2016, she has broadened her research interests from musculoskeletal aging to study all things aging, including such diverse topics as those involving the gut microbiome in older men and the effects of cancer treatments on aging in newly diagnosed breast cancer patients.
Professor of Medicine (General Medical Disciplines)
Current Research and Scholarly Interests My initial research activities involved antiretroviral and novel therapeutic treatments of HIV infection, understanding elements of HIV pathogenesis associated with acute HIV infection and post exposure prevention. My most recent scholarly activities concentrate on working as a team to capitalize on the data stored in electronic medical records, HIV disease modeling and using electronic medical records for outcome research and developing a mentorship program for early career scientists.
Afrin N. Kamal MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Bio Afrin Kamal is a board-certified gastroenterologist, who trained at Washington University in internal medicine, Cleveland Clinic in gastroenterology/hepatology, and most recently Stanford University in esophageal and motility diseases. Afrin shares a clinical passion in esophageal motility diseases with an an overlapping interest in health services and outcomes research.
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
Bio Beverley Kane, MD, was Board Certified in Family Medicine, then completed fellowships in Ob-Gyn (San Francisco Children's Hosptial) and Sports Medicine (London Univeristy). She has worked in the private practice of sports medicine; in medical informatics, specializing in doctor-patient communication (WebMD); and in stress management with her private practice, Horsensei Equine-Assisted Learning & THerapy (HEALTH). Her latest book, "Equine-imity--Stress Reduction and Emotional Self-Regulation in the Company of Horses," published 27 March 2021, can be seen at http://equine-imity.com/
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly Interests Our research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms
Michael S. Kapiloff, MD, PhD
Associate Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests Dr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html
Adjunct Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests Health services research
Studies on the cost and quality of health care
Health outcome measurement
Social determinants of health
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interests Completed a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.
Maya M. Kasowski
Assistant Professor of Medicine (Sean N Parker Center for Allergy and Asthma Research) of Pathology and, by courtesy, of Genetics
Bio I am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
Clinical Assistant Professor, Medicine - Vaden Health Center
Current Research and Scholarly Interests At Stanford University School of Medicine, one of our major goals is to translate research insights into practical advances that enhance and prolong life. We foster a two-way transfer of knowledge between research laboratories and patient-care settings. Our faculty, staff, postdoctoral scholars and students engage in interdisciplinary efforts to turn this knowledge into therapies that treat or prevent disease.
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Bio Tamiko Katsumoto, MD, is a Clinical Assistant Professor in the Division of Immunology and Rheumatology at Stanford University. She earned her MD from the University of California, San Francisco. She completed her internal medicine residency and rheumatology fellowship at UCSF, including a postdoc in the immunology lab of Dr. Arthur Weiss. Dr. Katsumoto’s research interests include the discovery of novel biomarkers to predict the development of immune-related adverse events in cancer patients on immune checkpoint inhibitor therapies, and optimizing the management of such complications. She serves as the director of the Stanford Immune Related Toxicity Working Group, a multidisciplinary group which aims to improve the quality of care of patients on checkpoint inhibitors. She is fascinated by the relationship between cancer and autoimmune diseases such as scleroderma and dermatomyositis, and the paraneoplastic manifestations of various cancers. She has spent time at Genentech, where she led several clinical trials in immunology.
Laurence Katznelson, MD
Professor of Neurosurgery and of Medicine (Endocrinology)
Current Research and Scholarly Interests Dr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
Instructor, Medicine - Cardiovascular Medicine
Bio Dr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018 as an Instructor in the Division of Cardiovascular Medicine. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He sees advanced heart failure patients in the clinic and attends CCU/heart failure service, and post-heart transplant and MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy in inherited cardiomyopathy and also conducting a device study in heart failure.
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Bio The management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
Ali Raza Khaki, MD
Clinical Assistant Professor, Medicine - Oncology
Bio Dr. Khaki is a hematologist/oncologist with board certification in oncology, hematology, and internal medicine. He is also a clinical assistant professor of oncology at Stanford University School of Medicine.
In his clinical practice, he treats patients all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. With each patient, he is devoted to providing exceptional, humanistic care. As a medical student, he was named to the national Gold Humanism Honor Society. As a resident, he received the Reza Gandjei Humanism Award.
His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He also has studied health care utilization and costs for end-of-life care of cancer patients.
Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.
He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. His work has appeared in publications including JAMA Oncology, Cancer Investigation, Clinical Genitourinary Cancer, the Journal of Urology, and Lancet. In addition, he is an editor for HemOnc.org and theMednet, the physician-only online community where members share clinical questions and answers.
Dr. Khaki is a member of the American Society of Clinical Oncology, American Society of Hematology, Multinational Association of Supportive Care in Cancer, and American Medical Informatics Association. He is on the Measure Steering Group committee and the Trainee and Early Career Council committee of the American Society of Clinical Oncology.
Saad A. Khan, MD
Assistant Professor of Medicine (Oncology)
Bio Saad A. Khan, MD is a medical oncologist focused on the treatment of head and neck, thyroid and lung cancers. His research interests include therapeutic clinical trials as well as mechanisms of reducing toxicities that patients experience. His research activities include ongoing clinical trials of targeted and immune therapy in aggressive thyroid malignancies. He is a member of the NRG Head and Neck Committee, the ECOG Head and Neck Core and Thoracic Committees and the National Cancer Institute’s Head and Neck Steering Committee Rare Tumor Task Force.
When not in clinic or the hospital he enjoys spending time with his family and 3 children, hiking and sitting on the beach.
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly Interests Cardiovascular disease in Pregnancy
Valvular Heart Disease
Heart Disease in South Asians
Women's Cardiovascular Disease
Kiran Kaur Khush, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests Dr. Khush's clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.
Professor (Research) of Medicine (General Internal Medicine), Emeritus
Current Research and Scholarly Interests My research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.
Gloria S. Kim
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly Interests Medical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests The lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
Seung K. Kim M.D., Ph.D.
Professor of Developmental Biology and, by courtesy, of Medicine (Endocrinology) and of Pediatrics (Endocrinology)
Current Research and Scholarly Interests We study the development of pancreatic islet cells using molecular, embryologic and genetic methods in several model systems, including mice, pigs, human pancreas, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. These approaches have informed efforts to generate replacement islets from renewable sources for diabetes.
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly Interests We are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
W. Ray Kim
Professor of Medicine (Gastroenterology and Hepatology)
Bio Chronic liver disease is one of the most common causes of premature death in Americans. My career goal is to improve the outcome of individuals with chronic liver disease by identifying the optimal means for diagnosis, monitoring, treatment and prevention. The path I have chosen to achieve this goal is through engagement in clinical epidemiology and patient-oriented, effectiveness research.
Since the development of the MELD score which recognizes the importance of renal function in the prognosis of patients with end stage liver disease, one of the areas that we have had intense interest has been acute and chronic renal injury in patients undergoing liver transplantation. Liver transplantation represents a unique opportunity for research, because of the potential for reversal of the renal injury as well as access to biological materials.
Clinical Instructor, Medicine - Primary Care and Population Health
Bio Dr Kim is a clinician-educator and staff physician at the Palo Alto VA, precepting residents on the VA homeless outreach rotation, managing a team of RNP/MDs supporting the medical care of veterans in four residential rehabilitation programs, and providing direct care of rural, community college, and homeless veterans through the Medical Outreach Section. Her research interests include measuring the impact of health information technology on primary care workflow in safety net settings, and improving communication skills and tolerance of ambiguity among medical trainees through the arts and humanities. After graduating with AB (Comp Lit/French) and MD from Brown University's Program in Liberal Medical Education, she completed internal medicine residency at the Santa Clara Valley Medical Center in San Jose, CA and a clinical research fellowship in the Division of General Internal Medicine/SFGH at UCSF, where she obtained a Master's in Advanced Studies and was nominated for a Kaiser Teaching award in 2008.
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly Interests Clinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
Abby C. King
Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly Interests My interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
Clinical Assistant Professor, Medicine
Current Research and Scholarly Interests Hypnosis for perioperative symptom management in elective orthopedic surgery.
Professor (Research) of Biomedical Data Science and of Medicine (BMIR)
Current Research and Scholarly Interests Co-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer
Joshua W. Knowles
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests Genetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH)
Gerald M. Reaven, MD, Professor of Endocrinology
Current Research and Scholarly Interests Our research interests are in the general area of cellular lipid and lipoprotein metabolism. The work is aimed primarily at understanding the mechanisms regulating cholesterol and triglyceride accumulation in cells. We utilize a variety of techniques from cell biology, biochemistry, and molecular biology.
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly Interests Drugs and toxins-associated pulmonary arterial hypertension, clinical outcomes research, acute kidney injury in pulmonary arterial hypertension